• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-1,2,3-三唑-色酮衍生物对乙酰胆碱酯酶和β-淀粉样蛋白聚集的抑制作用:全面的生物测定研究。

N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study.

机构信息

LAQV-REQUIMTE, University of Évora, Institute for Research and Advanced Studies, Rua Romão Ramalho, 59, 7000 Évora, Portugal.

Departamento de Química Orgánica, Facultad de Química, Universidad de Sevilla, Apartado 1203, E-41071 Seville, Spain.

出版信息

Bioorg Chem. 2020 May;98:103753. doi: 10.1016/j.bioorg.2020.103753. Epub 2020 Mar 19.

DOI:10.1016/j.bioorg.2020.103753
PMID:32200328
Abstract

Our goal was the evaluation of a series of N-1,2,3-triazole-isatin derivatives for multi-target activity which included cholinesterase (ChE) inhibition and β-amyloid (Aβ) peptide anti-aggregation. The compounds have shown considerable promise as butyrylcholinesterase (BuChE) inhibitors. Although the inhibition of eel acetylcholinesterase (eeAChE) was weak, the inhibitions against equine BuChE (eqBuChE) and human BuChE (hBuChE) were more significant with a best inhibition against eqBuChE of 0.46 μM. In some cases, these molecules gave better inhibitions for hBuChE than eqBuChE. For greater insights into their mode of action, molecular docking studies were carried out, followed by STD-NMR validation. In addition, some of these compounds showed weak Aβ anti-aggregation activity. Hepatotoxicity studies showed that they were non-hepatoxic and neurotoxicity studies using neurite outgrowth experiments led to the conclusion that these compounds are only weakly neurotoxic.

摘要

我们的目标是评估一系列 N-1,2,3-三唑-色胺衍生物的多靶点活性,包括胆碱酯酶(ChE)抑制和β-淀粉样肽(Aβ)肽抗聚集。这些化合物已显示出作为丁酰胆碱酯酶(BuChE)抑制剂的巨大潜力。虽然对鳗鱼乙酰胆碱酯酶(eeAChE)的抑制作用较弱,但对马源 BuChE(eqBuChE)和人源 BuChE(hBuChE)的抑制作用更为显著,对 eqBuChE 的最佳抑制作用为 0.46 μM。在某些情况下,这些分子对 hBuChE 的抑制作用优于 eqBuChE。为了更深入地了解它们的作用模式,进行了分子对接研究,并进行了 STD-NMR 验证。此外,这些化合物中的一些显示出较弱的 Aβ 抗聚集活性。肝毒性研究表明它们无肝毒性,神经毒性研究通过神经突生长实验得出结论,这些化合物仅具有较弱的神经毒性。

相似文献

1
N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study.N-1,2,3-三唑-色酮衍生物对乙酰胆碱酯酶和β-淀粉样蛋白聚集的抑制作用:全面的生物测定研究。
Bioorg Chem. 2020 May;98:103753. doi: 10.1016/j.bioorg.2020.103753. Epub 2020 Mar 19.
2
Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives.新型他克林-靛红席夫碱杂合衍生物的设计、合成与生物活性。
Bioorg Chem. 2019 Aug;89:103006. doi: 10.1016/j.bioorg.2019.103006. Epub 2019 May 21.
3
Novel pyridazinone derivatives as butyrylcholinesterase inhibitors.新型哒嗪酮衍生物作为丁酰胆碱酯酶抑制剂。
Bioorg Chem. 2019 Nov;92:103304. doi: 10.1016/j.bioorg.2019.103304. Epub 2019 Sep 18.
4
Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.多功能他克林-阿魏酸杂合物作为抗阿尔茨海默病胆碱酯酶抑制剂的合成、药理学及分子对接
J Enzyme Inhib Med Chem. 2018 Dec;33(1):496-506. doi: 10.1080/14756366.2018.1430691.
5
Design, synthesis and biological evaluation of benzo[e][1,2,4]triazin-7(1H)-one and [1,2,4]-triazino[5,6,1-jk]carbazol-6-one derivatives as dual inhibitors of beta-amyloid aggregation and acetyl/butyryl cholinesterase.苯并[e][1,2,4]三嗪-7(1H)-酮和[1,2,4]-三嗪并[5,6,1-jk]咔唑-6-酮衍生物的设计、合成及作为β-淀粉样蛋白聚集和乙酰/丁酰胆碱酯酶双重抑制剂的生物评价。
Eur J Med Chem. 2012 Dec;58:84-97. doi: 10.1016/j.ejmech.2012.10.003. Epub 2012 Oct 11.
6
New pyridine derivatives as inhibitors of acetylcholinesterase and amyloid aggregation.新型吡啶衍生物作为乙酰胆碱酯酶抑制剂和淀粉样蛋白聚集抑制剂
Eur J Med Chem. 2017 Dec 1;141:197-210. doi: 10.1016/j.ejmech.2017.09.022. Epub 2017 Sep 18.
7
1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.基于 1-苄基吡咯烷-3-胺的 BuChE 抑制剂具有抗聚集、抗氧化和金属螯合特性,可用作治疗阿尔茨海默病的多功能药物。
Eur J Med Chem. 2020 Feb 1;187:111916. doi: 10.1016/j.ejmech.2019.111916. Epub 2019 Nov 26.
8
Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT receptor with anti-aggregation properties against amyloid-beta and tau.发现基于 1-(苯磺酰基)-1H-吲哚的多功能配体,针对胆碱酯酶和 5-HT 受体,具有抗聚集特性,可对抗淀粉样β和 tau。
Eur J Med Chem. 2021 Dec 5;225:113783. doi: 10.1016/j.ejmech.2021.113783. Epub 2021 Aug 19.
9
Novel chromanone-dithiocarbamate hybrids as multifunctional AChE inhibitors with β-amyloid anti-aggregation properties for the treatment of Alzheimer's disease.新型色满酮二硫代氨基甲酸盐类化合物作为多功能乙酰胆碱酯酶抑制剂,具有β-淀粉样蛋白抗聚集特性,可用于治疗阿尔茨海默病。
Bioorg Chem. 2019 Aug;89:103027. doi: 10.1016/j.bioorg.2019.103027. Epub 2019 May 31.
10
Synthesis, biological evaluation and molecular modeling of novel triazole-containing berberine derivatives as acetylcholinesterase and β-amyloid aggregation inhibitors.新型含三氮唑的黄连素衍生物的合成、生物评价及分子模拟作为乙酰胆碱酯酶和β-淀粉样蛋白聚集抑制剂。
Bioorg Med Chem. 2011 Apr 1;19(7):2298-305. doi: 10.1016/j.bmc.2011.02.025. Epub 2011 Feb 18.

引用本文的文献

1
Accessing Promising Passerini Adducts in Anticancer Drug Design.在抗癌药物设计中获取有前景的Passerini加合物。
Molecules. 2024 Nov 23;29(23):5538. doi: 10.3390/molecules29235538.
2
Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies.评估 1,2,3-三唑并[4,5-d]嘧啶二酮杂合体对胆碱酯酶的潜在抑制作用:计算机模拟、体外和体内研究。
Int J Mol Sci. 2024 Oct 17;25(20):11153. doi: 10.3390/ijms252011153.
3
The Ugi4CR as effective tool to access promising anticancer isatin-based α-acetamide carboxamide oxindole hybrids.
Ugi4CR作为一种有效的工具,用于获取有前景的基于异吲哚酮的α-乙酰酰胺羧酰胺氧化吲哚杂化物抗癌药物。
Beilstein J Org Chem. 2024 May 27;20:1213-1220. doi: 10.3762/bjoc.20.104. eCollection 2024.
4
Computational identification of potential acetylcholinesterase (AChE) and monoamine oxidase-B inhibitors from : a case study of Alzheimer's disease (AD).从……中计算鉴定潜在的乙酰胆碱酯酶(AChE)和单胺氧化酶-B抑制剂:以阿尔茨海默病(AD)为例的研究
In Silico Pharmacol. 2024 May 31;12(1):49. doi: 10.1007/s40203-024-00214-3. eCollection 2024.
5
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities.含1,2,3-三唑杂化物及其潜在抗胆碱酯酶活性概述
Pharmaceuticals (Basel). 2023 Jan 24;16(2):179. doi: 10.3390/ph16020179.
6
-1,2,3-Triazole-isatin derivatives: anti-proliferation effects and target identification in solid tumour cell lines.1,2,3-三唑-异吲哚酮衍生物:实体瘤细胞系中的抗增殖作用及靶点鉴定
RSC Med Chem. 2022 Jun 10;13(8):970-977. doi: 10.1039/d2md00044j. eCollection 2022 Aug 17.
7
Exploration of the Detailed Structure-Activity Relationships of Isatin and Their Isomers As Monoamine Oxidase Inhibitors.异吲哚酮及其异构体作为单胺氧化酶抑制剂的详细构效关系探索。
ACS Omega. 2022 May 5;7(19):16244-16259. doi: 10.1021/acsomega.2c01470. eCollection 2022 May 17.
8
Anticancer Compounds Based on Isatin-Derivatives: Strategies to Ameliorate Selectivity and Efficiency.基于异吲哚酮衍生物的抗癌化合物:提高选择性和效率的策略。
Front Mol Biosci. 2021 Feb 4;7:627272. doi: 10.3389/fmolb.2020.627272. eCollection 2020.